Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Convalife Pharmaceuticals logo — Pioneering the future of tumor disease treatment through adv...

Convalife Pharmaceuticals

Pioneering the future of tumor disease treatment through advanced pharmaceutical research and development

Founded 2018 Series C Total: $200.00M Biopharma, Pharmaceutical

General Information

Company Name Convalife Pharmaceuticals
Founded Year 2018
Industries Biopharma, Pharmaceutical
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Convalife Pharmaceuticals. To contact Convalife Pharmaceuticals, visit fukang.panyouwl.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Convalife Pharmaceuticals compare?

A PDF of Convalife Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Convalife Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Convalife Pharmaceuticals

Convalife Pharmaceuticals, founded in 2018, is pioneering the future of tumor disease treatment through advanced pharmaceutical research and development. Specializing in the Biopharma and Pharmaceutical industries, the company's slogan embodies its commitment to innovation. In December 2023, Convalife Pharmaceuticals secured a significant milestone with a CNY100.00M Series C investment from Xicheng Zhiyuan, signifying a vote of confidence in the company's vision and potential impact in the field of tumor disease treatment. As the company continues to advance its research and development efforts, this noteworthy investment is poised to fuel Convalife Pharmaceuticals' mission to make strides in enhancing treatment options for tumor diseases.

Business keywords: pharmaceutical research, drug development, tumor diseases, cancer treatment, oncology, pharmaceutical company, innovation, medical research, clinical trials

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C CNY100.00M 1
Xicheng Zhiyuan
29 Dec 2023
Series B CNY100.00M 2
Jointown Pharmaceutical Group
Jointown Pharmaceutical Group, Shangyu Hangzhou Bay Economic Development Zone Holding Group
03 Jan 2023

Convalife Pharmaceuticals Alternatives & Competitors

View All Alternatives
Convalife Pharmaceuticals vs
Nirogy Therapeutics
Nirogy Therapeutics

Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing therapeuti...

Series A
2-10 employees
Biopharma, Biotechnology
Convalife Pharmaceuticals vs
Day One Biopharmaceuticals
Day One Biopharmaceuticals United States

Cancer drug development comes of age.

Post-IPO Equity
190 employees
Biopharma, Biotechnology
Convalife Pharmaceuticals vs
Kanova
Kanova

Pioneering advanced therapies in immuno-oncology and autoimmune diseases.

Series B
2-10 employees
Biopharma, Health and Wellness
View all alternatives

FAQ About Convalife Pharmaceuticals

Pioneering the future of tumor disease treatment through advanced pharmaceutical research and development
Convalife Pharmaceuticals was founded in 2018.
Convalife Pharmaceuticals operates in Biopharma and Pharmaceutical. Its work centres on pharmaceutical research, drug development, tumor diseases and cancer treatment.
Convalife Pharmaceuticals has completed 2 funding rounds, raising a total of $200.00M. The latest funding stage is Series C.
Top alternatives and competitors to Convalife Pharmaceuticals include Nirogy Therapeutics, Day One Biopharmaceuticals, Kanova, OncXerna Therapeutics , Cage Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Convalife Pharmaceuticals and Nirogy Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Convalife Pharmaceuticals, https://bouncewatch.com/company/convalife-pharmaceuticals, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout